Ligand–receptor interaction platforms and their applications for drug discovery

By Ye Fang. 2012

115 citations recorded by the source corpus.

Subfields: Computational Theory and Mathematics, Molecular Biology, Organic Chemistry, Computational Chemistry & Drug Discovery

Citations in the corpus

• Molecular Docking and Structure-Based Drug Design Strategies (2015, neutral): “Next, evaluations of biological properties, such as potency, affinity and efficacy, are carried out using diverse experimental platforms [16].”
• Surface Plasmon Resonance Imaging Sensors: A Review (2014, unknown): “Since then, surface plasmon resonance (SPR) imaging has found rapid increasing research interests [2–5] and wide applications in drug discovery [6], biomarker screening [7], nucleic acid detection [5], food safety [8, 9], and environmental monitor-”
• A Structure-Based Drug Discovery Paradigm (2019, unknown): “Biological properties like efficacy, affinity, and potency of the selected compounds are evaluated by experimental methods [17].”